CytomX Therapeutics CTMX
NASDAQ CTMX
$2.75 +0.06 (+2.23%)
At close: Sep 29, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) EV to EBITDA (2024 - 2025)

Updated

CytomX Therapeutics' (CTMX) EV to EBITDA stood at 16.18 in Q3 2025, compared with -2.95 a year earlier and up 436.1% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) EV to EBITDA (2024 - 2025) Analysis & Trends

On a TTM basis, CytomX Therapeutics' EV to EBITDA came in at 2.38 as of Sep 30, 2025; for FY2024, it came in at -0.68.

  • Per Business Quant, the preceding three quarters came in at 3.02 (Q2 2025), -0.75 (Q1 2025) and -0.68 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 CytomX Therapeutics 586.15 Mn -371.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 16.18
Jun 30, 2025 3.02
Mar 31, 2025 -0.75
Dec 31, 2024 -0.68
Sep 30, 2024 -2.95
Jun 30, 2024 -5.50
Mar 31, 2024 2.22
API Access

CytomX Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CTMX&period=max&api_key=YOUR_API_KEY